Tumor-infiltrating lymphocytes in the immunotherapy era

ST Paijens, A Vledder, M de Bruyn… - Cellular & molecular …, 2021 - nature.com
The clinical success of cancer immune checkpoint blockade (ICB) has refocused attention
on tumor-infiltrating lymphocytes (TILs) across cancer types. The outcome of immune …

Radiomics and radiogenomics in gliomas: a contemporary update

G Singh, S Manjila, N Sakla, A True, AH Wardeh… - British journal of …, 2021 - nature.com
The natural history and treatment landscape of primary brain tumours are complicated by the
varied tumour behaviour of primary or secondary gliomas (high-grade transformation of low …

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment

E Verdugo, I Puerto, MÁ Medina - Cancer Communications, 2022 - Wiley Online Library
Glioblastoma multiforme (GBM) is the most aggressive and common malignant primary brain
tumor. Patients with GBM often have poor prognoses, with a median survival of∼ 15 months …

Applications of artificial intelligence in the analysis of histopathology images of gliomas: a review

JP Redlich, F Feuerhake, J Weis, NS Schaadt… - npj Imaging, 2024 - nature.com
In recent years, the diagnosis of gliomas has become increasingly complex. Analysis of
glioma histopathology images using artificial intelligence (AI) offers new opportunities to …

Radiomics for characterization of the glioma immune microenvironment

N Khalili, AF Kazerooni, A Familiar, D Haldar… - NPJ precision …, 2023 - nature.com
Increasing evidence suggests that besides mutational and molecular alterations, the
immune component of the tumor microenvironment also substantially impacts tumor …